FDA Approves Leqembi® (Lecanemab-Irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease
FDA批准Leqembi®(Lecanemab-Irmb)靜脈維護給藥用於治療早期阿爾茨海默病
FDA Approves Leqembi® (Lecanemab-Irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease
FDA批准Leqembi®(Lecanemab-Irmb)靜脈維護給藥用於治療早期阿爾茨海默病
譯文內容由第三人軟體翻譯。
評論(0)
請選擇舉報原因